LLVK

LLVK is a selective IκB phosphorylation inhibitor. LLVK reduces LPS-induced pro-inflammatory cytokines (IL-1β, IL-6, TNF-α) . LLVK is promising for research of inflammatory bowel disease and rheumatoid arthritis[1].

Product Specifications

CAS Number

[798540-36-0]

UNSPSC

12352209

Target

IKK; NF-κB

Related Pathways

NF-κB

Applications

COVID-19-immunoregulation

Field of Research

Inflammation/Immunology

Smiles

NCCCC[C@@H](C(O)=O)NC([C@H](C(C)C)NC([C@H](CC(C)C)NC([C@@H](N)CC(C)C)=O)=O)=O

Molecular Formula

C23H45N5O5

Molecular Weight

471.63

References & Citations

[1]Liu W, et al. Alternation in sequence features and their influence on the anti-inflammatory activity of soy peptides during digestion and absorption in different enzymatic hydrolysis conditions. Food Chem. 2025 Apr 15;471:142824.